Vimarsana
Biggest News Aggregation in the World

Page 15 - Upstream Processing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Upstream Processing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Upstream Processing Today - Breaking & Trending Today

Clean Biologics gains foothold in North American market, adds vaccine and biologics focused CDMO to group - Vimarsana News

Clean Biologics gains foothold in North American market, adds vaccine and biologics focused CDMO to group

Clean Biologics gains foothold in North American market, adds vaccine and biologics focused CDMO to group French pharma services provider, Clean Biologics, has acquired Canadian CDMO, Biodextris, in a move it says will boost its analytical and process development, and early-phase clinical manufacturing and quality control testing services for clients in the vaccine and biologics industries. The move also means it gets a platform to establish a presence on the North American market with a view to increasing its activities in this region. The financial terms of the t...

Catalent looks to meet needs of expanding CGT market, completes expansion work at biologics drug substance facility - Vimarsana News

Catalent looks to meet needs of expanding CGT market, completes expansion work at biologics drug substance facility

Subscribe Catalent looks to meet needs of expanding CGT market, completes expansion work at biologics drug substance facility By Jane Byrne Contract development and manufacturing organization, Catalent, has invested in the capabilities at its clinical supply services facility in Philadelphia, in the US, to further support biotech firms developing cell and gene therapies. The financial outlay has enabled part of the facility to be dedicated to the safe handling of cell and gene therapy (CGT) samples, including the install...

LabRoots' Bioprocessing 2021 Online Event Highlights Innovations in Bioproduction, Downstream Processing, Novel Biotherapeutics, and Digital Biomanufacturing - Vimarsana News

LabRoots' Bioprocessing 2021 Online Event Highlights Innovations in Bioproduction, Downstream Processing, Novel Biotherapeutics, and Digital Biomanufacturing

LabRoots’ Bioprocessing 2021 Online Event Highlights Innovations in Bioproduction, Downstream Processing, Novel Biotherapeutics, and Digital Biomanufacturing Share Article YORBA LINDA, Calif. (PRWEB) April 01, 2021 LabRoots, the leading scientific social networking website, offering premier, interactive virtual events and webinars, is pleased to announce its Bioprocessing Virtual Event to be hosted on April 7th, 2021 providing a premier forum for three consecutive years solving today’s challenges, and how to improve process e...

Source: prweb.com
Aldevron expands manufacturing capabilities in Madison - Vimarsana News

Aldevron expands manufacturing capabilities in Madison

Aldevron expands manufacturing capabilities in Madison Part of Aldevron’s expansion is a fermentation suite that will allow the company to expand its projects’ scope and scale. Submitted photo From February through June, we will highlight the ways that UW–Madison powers the state’s economy through research and innovation, educates the next generation and reaches out to Wisconsinites to improve their lives. February’s theme is Economic Prosperity. Watch for more at #CantStopABadger and #UWimpact on social media. Your support can help us continue this work.  February 10, Aldevron h...

Source: wisc.edu
US Antibody Production Market Size | Industry Analysis and Opportunity Assessment 2021-2027 | Covid- - Vimarsana News

US Antibody Production Market Size | Industry Analysis and Opportunity Assessment 2021-2027 | Covid-

Search jobs US Antibody Production Market Size | Industry Analysis and Opportunity Assessment 2021-2027 | Covid-19 Impact Analysis Pune, Maharashtra, India, February 10 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Antibody Production Market is valued at USD 9.43 Billion in 2018 and expected to reach USD 22.46 Billion by 2025 with a CAGR of 13.2% over the forecast period. Increasing prevalence of chronic diseases such as cancer, rheumatic heart disease, and arthritis which require antibodies treatment to cure with extensive research and d...